- Home
- TXMD vs BFRI Comparison
TXMD vs BFRI Comparison
Compare TXMD & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- BFRI
- Stock Information
- Founded
- TXMD 2008
- BFRI 1997
- Country
- TXMD United States
- BFRI United States
- Employees
- TXMD N/A
- BFRI N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- TXMD Health Care
- BFRI Health Care
- Exchange
- TXMD Nasdaq
- BFRI Nasdaq
- Market Cap
- TXMD 12.3M
- BFRI 10.6M
- IPO Year
- TXMD N/A
- BFRI 2021
- Fundamental
- Price
- TXMD $1.23
- BFRI $1.07
- Analyst Decision
- TXMD
- BFRI Strong Buy
- Analyst Count
- TXMD 0
- BFRI 1
- Target Price
- TXMD N/A
- BFRI $2.75
- AVG Volume (30 Days)
- TXMD 506.6K
- BFRI 87.4K
- Earning Date
- TXMD 11-12-2025
- BFRI 11-12-2025
- Dividend Yield
- TXMD N/A
- BFRI N/A
- EPS Growth
- TXMD N/A
- BFRI N/A
- EPS
- TXMD N/A
- BFRI N/A
- Revenue
- TXMD $2,559,000.00
- BFRI $39,188,000.00
- Revenue This Year
- TXMD $427.09
- BFRI $9.70
- Revenue Next Year
- TXMD N/A
- BFRI $12.58
- P/E Ratio
- TXMD N/A
- BFRI N/A
- Revenue Growth
- TXMD 156.93
- BFRI 11.20
- 52 Week Low
- TXMD $0.70
- BFRI $0.54
- 52 Week High
- TXMD $2.44
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- TXMD 59.44
- BFRI 57.98
- Support Level
- TXMD $1.20
- BFRI $0.95
- Resistance Level
- TXMD $1.37
- BFRI $1.15
- Average True Range (ATR)
- TXMD 0.12
- BFRI 0.06
- MACD
- TXMD 0.02
- BFRI 0.01
- Stochastic Oscillator
- TXMD 29.85
- BFRI 69.04
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.